Positive Top-Line Results For Pfizer’s Lyrica In Phase 3 Study Of Patients With Fibromyalgia In Japan | Business Wire
Links shared publicly online about this topic.
- 167total visits
Positive Top-Line Results For Pfizer’s Lyrica In Phase 3 Study Of Patients With Fibromyalgia In Japan | Business Wire
Pfizer Japan announced today the top-line results for Lyrica (pregabalin) Study A0081208 – Randomized, Double-Blind, Multicenter, Placebo-Contro
View full resource at businesswire.com
Tags: Seizure Medication, Fibromyalgia, Fibromyalgia Medication, Neuropathic Pain Medication, Phase 3 Clinical Trial, Lyrica, Pfizer, Epilepsy Medication
Most Recently Shared on July 6, 2011 at 4:25 am By:
Positive Top-Line Results For Pfizer’s Lyrica In Phase 3 Study Of Patients With Fibromyalgia In Japan: TOKYO & N... http://bit.ly/n2muaS
Advertisement
